SEC Form 4 · accession 0001171843-16-010963
IMMUNOMEDICS INC · IMMU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Garone
Officer — CHIEF FINANCIAL OFFICER
Period of report
Jun 27, 2016
Accepted (ET)
Jul 5, 2016 · 5:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000722830
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1 | $2.00 | Jun 27, 2016 | A | 40,000 | A | — | Jun 27, 2023 | Common Stock, par value $0.01 per share | 40,000 | 40,000 | D |
Explanation of responses
- F1The reporting person was granted stock options pursuant to the Immunomedics, Inc. 2014 Long-Term Incentive Plan, and vest 25% on the first anniversary of the date of grant and 6.25% on a quarterly basis thereafter.